The Effects of Agricultural Trade Liberalisation under the Doha Development Agenda with Special Reference to the Asia Pacific Region: A Brief Survey

The main purpose of this paper is to survey the results of recent quantitative studies on the effects of Agricultural Trade Liberalization with special reference to the Asia-Pacific region under the July Framework Agreement or the “July Package” of the Doha Development Agenda, DDA (the decision adopted by the General Council of the WTO on 1 August 2004, see WTO, 2004, WT/L/579).Agricultural Trade Liberalization, Doha Development

Studies in Trade and Investment - AGRICULTURAL TRADE - PLANTING THE SEEDS OF REGIONAL LIBERALIZATION IN ASIA

this chapter attempts to evaluate the impact of agricultural trade reform in the Asia-Pacific region, focusing on RTAs.Agricultural trade liberalization, Asia-Pacific region, preferential trade agreements

Trade Liberalisation and Income Distribution: Evidence from a Small Open Economy

Abstract: Over the last few decades there has been a great deal of interest in investigating the link between trade liberalisation and income distribution in developing countries. Although there is a significant amount of empirical evidence to support the positive link between trade liberalisation and growth, the evidence on the relationship between trade liberalisation and income distribution among different household groups has been inconclusive. This study investigates the effects of trade liberalisation on income distribution in the Sri Lankan economy using a computable general equilibrium model. In terms of income distribution it can be observed that tariff reduction in manufacturing industries tends to widen the income gap between the low and the high income earners. Understanding these distributional effects of trade liberalisation will help in designing better targeted and robust welfare programmes in order to mitigate the adjustment costs of further liberalisation in developing countries like Sri Lanka

Phenotypic and genotypic distribution of ESBL, AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae in community-acquired and hospital-acquired urinary tract infections in Sri Lanka

Objectives: Although Sri Lanka belongs to a region with a high prevalence of extended-spectrum β-lactamase (ESBL), AmpC β-lactamase and carbapenemase-producing Enterobacteriaceae, data regarding antimicrobial resistance (AMR) is limited. We studied the prevalence and diversity of β-lactamases produced by Enterobacteriaceae urinary pathogens from two hospitals in the Western Province of Sri Lanka. Methods: ESBL, AmpC β-lactamase and carbapenemase production was detected by phenotypic testing followed by genotyping. Results: The species responsible for urinary tract infections (UTI) were Escherichia coli (69%), Klebsiella pneumoniae (16%) and Enterobacter sp (6%). The prevalence of ESBL (50%), AmpC β-lactamase (19%) and carbapenemase (11%) phenotypes was high, and greater in hospital-acquired (HA-UTI) (75%) than in community-acquired UTI (CA-UTI) (42%). Identification of CA-UTI caused by carbapenemase-producing Enterobacteriaceae (5%) is alarming. Only one ESBL gene, blaCTX- M-15, was detected. AmpC β-lactamase genes found in E. coli and K. pneumoniae were blaCMY-2, blaCMY-42 and blaDHA-1, while Enterobacter sp. carried blaACT-1. Carbapenemase genes were blaNDM-1, blaNDM-4, blaOXA-181 and blaOXA-232, while blaKPC, blaIMP and blaVIM were absent. Co-occurrence of multiple bla genes, with some isolates harbouring six different bla genes, was common. Carbapenem-resistant isolates without carbapenemase genes displayed mutations in the outer membrane porin genes, ompF of E. coli and ompK36 of K. pneumoniae. Factors associated with UTI with β-lactamase-producing Enterobacteriaceae were age ≥50 years, previous hospitalization, presence of an indwelling urinary catheter, history of diabetes mellitus or other chronic illness and recurrent urinary tract infections. Conclusion: This study adds to the currently scarce data on AMR in Sri Lanka

MANAGING THE TOURISM-LED DEVELOPMENT STRATEGY IN POST-WAR SRI LANKA

The Sri Lankan tourism industry has been booming since the end of war in 2009. Considering the key role that tourism can play in post-war economic development, the Sri Lankan government launched a Tourism Development Strategy (TDS). This study has evaluated the feasibility of achieving the targets of the TDS by building a simple tourism demand model and by undertaking a qualitative comparative assessment with a selected tourism booms in a number of war-affected countries. The findings suggest that the TDS targets are achievable provided the country manages to expand supply of tourism related infrastructure (hard as well as soft) in a price competitive manner

Recognition of skin malignancy by general practitioners: observational study using data from a population-based randomised controlled trial

Skin malignancy is an important cause of mortality in the United Kingdom and is rising in incidence every year. Most skin cancer presents in primary care, and an important determinant of outcome is initial recognition and management of the lesion. Here we present an observational study of interobserver agreement using data from a population-based randomised controlled trial of minor surgery. Trial participants comprised patients presenting in primary care and needing minor surgery in whom recruiting doctors felt to be able to offer treatment themselves or to be able to refer to a colleague in primary care. They are thus relatively unselected. The skin procedures undertaken in the randomised controlled trial generated 491 lesions with a traceable histology report: 36 lesions (7%) from 33 individuals were malignant or pre-malignant. Chance-corrected agreement (κ) between general practitioner (GP) diagnosis of malignancy and histology was 0.45 (0.36–0.54) for lesions and 0.41 (0.32–0.51) for individuals affected with malignancy. Sensitivity of GPs for the detection of malignant lesions was 66.7% (95% confidence interval (CI), 50.3–79.8) for lesions and 63.6% (95% CI, 46.7–77.8) for individuals affected with malignancy. The safety of patients is of paramount importance and it is unsafe to leave the diagnosis and treatment of potential skin malignancy in the hands of doctors who have limited training and experience. However, the capacity to undertake all of the minor surgical demand works demanded in hospitals does not exist. If the capacity to undertake it is present in primary care, then the increased costs associated with enhanced training for general medical practitioners (GPs) must be borne

IN-VITRO CALLUS FORMATION OF RED SANDALWOOD (Pterocarpus santalinus L.) AS AFFECTED BY EXPLANT TYPE AND DIFFERENT LEVELS OF 2,4-D AND BAP

Pterocarpus santalinus is a valuable medicinal plant, now included in red listof endangered plants under IUCN guidelines. Distribution of this plant in SriLanka is very limited and the local demand for ayurvedic purposes is stillunreached. As conventional propagation techniques are not satisfactory,possibilities in in-vitro techniques seem to be promising, and callus culture isone aspect that has to be studied. Leaf parts, cotyledon parts, root segments,inter-nodal segments, and nodal segments from in-vitro seedlings were usedas explants. 2,4-D and BAP were used separately in six differentconcentrations (1 mg/l - 6 mg/l) for callus initiation Full strength MS medium(Murashige and Skoog, 1962) was used with 30 g/l of sucrose and 8 g/l agaras the culture medium. Callus formation could be observed in every explant.However, large clumps of creamy white callus were obtained from nodalsegments. Callus formation in root segments was very poor and showedbrown color. In nodal segments, callus formation was started within twoweeks and large clumps of callus were observed while slight swellin~occurring on root segments, leaf parts and in cotyledon parts at the end of 41week. Callus formation was best when the culture medium was supplementedwith 3 mg/l of BAP. Though callus formation could be observed in 2,4-D,amount of callus formed was poor. Present studies revealed that MS mediumsupplemented with 3 mg/l BAP is ideal for callus induction in Pterocarpussantalinus and possibility of using nodal segments as initial explants

NONO enhances mRNA processing of super-enhancer-associated GATA2 and HAND2 genes in neuroblastoma

High-risk neuroblastoma patients have poor survival rates and require better therapeutic options. High expression of a multifunctional DNA and RNA-binding protein, NONO, in neuroblastoma is associated with poor patient outcome; however, there is little understanding of the mechanism of NONO-dependent oncogenic gene regulatory activity in neuroblastoma. Here, we used cell imaging, biochemical and genome-wide molecular analysis to reveal complex NONO-dependent regulation of gene expression. NONO forms RNA- and DNA-tethered condensates throughout the nucleus and undergoes phase separation in vitro, modulated by nucleic acid binding. CLIP analyses show that NONO mainly binds to the 5′ end of pre-mRNAs and modulates pre-mRNA processing, dependent on its RNA-binding activity. NONO regulates super-enhancer-associated genes, including HAND2 and GATA2. Abrogating NONO RNA binding, or phase separation activity, results in decreased expression of HAND2 and GATA2. Thus, future development of agents that target RNA-binding activity of NONO may have therapeutic potential in this cancer context

Development of siRNA-loaded lipid nanoparticles targeting long non-coding RNA LINC01257 as a novel and safe therapeutic approach for t(8;21) pediatric acute myeloid leukemia

Standard of care therapies for children with acute myeloid leukemia (AML) cause potent off-target toxicity to healthy cells, highlighting the need to develop new therapeutic approaches that are safe and specific for leukemia cells. Long non-coding RNAs (lncRNAs) are an emerging and highly attractive therapeutic target in the treatment of cancer due to their oncogenic functions and selective expression in cancer cells. However, lncRNAs have historically been considered ‘undruggable’ targets because they do not encode for a protein product. Here, we describe the development of a new siRNA-loaded lipid nanoparticle for the therapeutic silencing of the novel oncogenic lncRNA LINC01257. Transcriptomic analysis of children with AML identified LINC01257 as specifically expressed in t(8;21) AML and absent in healthy patients. Using NxGen microfluidic technology, we efficiently and reproducibly packaged anti-LINC01257 siRNA (LNP-si-LINC01257) into lipid nanoparticles based on the FDA-approved Patisiran (Onpattro®) formulation. LNP-si-LINC01257 size and ζ-potential were determined by dynamic light scattering using a Malvern Zetasizer Ultra. LNP-si-LINC01257 internalization and siRNA delivery were verified by fluorescence microscopy and flow cytometry analysis. lncRNA knockdown was determined by RT-qPCR and cell viability was characterized by flow cytometry-based apoptosis assay. LNP-siRNA production yielded a mean LNP size of ~65 nm with PDI ≤ 0.22 along with a >85% siRNA encapsulation rate. LNP-siRNAs were efficiently taken up by Kasumi-1 cells (>95% of cells) and LNP-si-LINC01257 treatment was able to successfully ablate LINC01257 expression which was accompanied by a significant 55% reduction in total cell count following 48 h of treatment. In contrast, healthy peripheral blood mononuclear cells (PBMCs), which do not express LINC01257, were unaffected by LNP-si-LINC01257 treatment despite comparable levels of LNP-siRNA uptake. This is the first report demonstrating the use of LNP-assisted RNA interference modalities for the silencing of cancer-driving lncRNAs as a therapeutically viable and non-toxic approach in the management of AML